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ABSTRACTSAims: Of all breast lumps in young women, very few are malignant. Some
patients may not require all elements of triple assessment including those
with clearly identiﬁed benign conditions with no other suspicious features
identiﬁed clinically and radiologically. Aim of this study was to see if
biopsy of clinically and radiologically benign breast lumps of women under
30 years is necessary.
Methods: Retrospective study of women under 30 years presenting with
breast symptoms between December 2000 to January 2010.
Results: There were 864 patients. 612 had FNA and 252 CB. 544 met the
inclusion criteria. There were 496 (U2), 39 (U3) and 9 (U3+) on ultrasonog-
raphy. Of the 496 U2, 495 patients pathology was benign (B1/B2). All U3
patient's pathologywasbenign.AllU3+patientspathologyconﬁrmedcancer.
9 cases of U4/5 all conﬁrmed cancer on pathology.1 U2was reported as a C4.
Conclusions: 495 clinically and radiologically benign cases were proven to
have benign disease on FNA/CB. If there is a discrepancy between clinical
and radiological ﬁndings there should be a low threshold for biopsy.
Otherwise it may be safe to opt out of needle biopsy as it avoids unnec-
essary morbidity and use of precious resources.
0106: A RETROSPECTIVE STUDY OF AXILLARY LYMPH NODE CLEARANCE
FOR PATIENTS DIAGNOSED WITH EARLY BREAST CANCER AND
AXILLARY LYMPH NODE INVOLVEMENT
Suet May Chan 2, Vivien Ng 1, Stephen Courtney 1, Brendon Smith 1, Hilary
Umeh 1, Pankaj Roy 2. 1Royal Berkshire Hospital, Reading, Berkshire, UK;
2 John Radcliffe Hospital, Oxford, Oxfordshire, UK
Aim: Axillary nodal status is the most important prognostic indicator that
inﬂuences adjuvant therapy. Sentinel lymph node biopsy (SLNB) is the
standard procedure performed to stage the axilla. The current standard is
to perform axillary node clearance (ANC) if there is evidence of lymph node
(LN) metastases. This study aims to assess the number of positive LN on
ANC following a positive SLNB or biopsy on clinical/ultrasound assessment.
Methods: Patients with ANC (January 2008 to December 2009) were
identiﬁed along with LN yields on SLNB and ANC. Clinical-pathological
parameters and treatment details were also collected. ANC was performed
for three groups: SLNB + micrometastasis, SLNB + macrometastasis and
positive axillary LN on clinical/ultrasound-guided biopsy.
Results: 170 ANC were performed in the two-year period. More than 40%
of patients with macrometastasis on SLNB had further positive LN on ANC.
Only 8% of patients with micrometastasis were found to have residual
axillary disease (p<0.001, Fisher's exact test). Completion ANC did not
provide any additional information to alter adjuvant treatment in patients
with micrometastasis.
Conclusion: The limited role of completion ANC in patients with SLNB +
micrometastasis is highlighted and therefore is likely to have an impact on
management of early breast cancer.
0112: FIVE YEARS AFTER INTRODUCTION, HAVE STANDARDISED
REFERRAL FORMS REDUCED THE NUMBER OF INAPPROPRIATE
REFERRALS TO BREAST CLINIC?
Valentina Lefemine, Gary Osborn, Anne marie Mainwaring, Sumit
Goyal. Breast Centre, Cardiff, UK
Introduction: In August 2005 new referral guidelines and updated referral
forms were issued to GP's in Cardiff with the aim of reducing unnecessary
referrals to breast clinic. An audit of 203 referral letters showed that 53% of
patients were referred using the new style form. 55% of referrals were
deemed inappropriate. After ﬁve years we aim to assess the impact of
standardised referral forms on inappropriate referrals to breast clinic.
Methods: A prospective audit of GP referrals to the breast clinic in June and
July 2010 was performed.
Results: 145 patients were included. 75% of patients were referred using
the referral forms but 58% of these were ﬁlled incompletely. Concordance
between GP and consultant ﬁndings was similar for written and form
referrals (65% for breast lumps, 54% and 59% for pain and 100% and 57% for
discharge respectively). Overall 8% referrals were deemed inappropriate
using national guidelines, of which 7 (6%) used the standardised form and
5 (14%) were letters. All patients referred inappropriately had a normal
diagnosis, none required a biopsy and all were discharged from clinic.
Conclusion: After ﬁve years, the majority of referrals to the breast clinic
are made using the standard referral form. The number of inappropriate
referrals has fallen to 8%.0113: MASTALGIA – ARE WE CARING IN THE COMMUNITY?
Valentina Lefemine, Julie Cornish, Elle Javad, Walid Abou-Samra. Glan
clwyd Hospital, Rhyl, UK
Introduction: Referral guidelines for mastalgia are well published. Breast
pain with no other clinical concern should be managed initially in
a primary care setting. Our aim was to look into the management of
mastalgia in the community and have an understanding on whether
guidelines are followed.
Method: A questionnaire was posted to all GP surgeries that referred to
our institution.
Results: 41 responses were received (34% response rate). 95% percent of
GPs consulted 1-5 women with mastalgia every month. 24% of GPs were
aware of referral guidelines for patients presenting with breast pain. 37% of
GPs refer a patient with mastalgia to the breast clinic at their ﬁrst
presentation, mostly as ‘urgent' or ‘soon' referrals. All respondent GPs
would initiate some form of management for mastalgia.
Conclusion: Mastalgia is the commonest breast symptom presenting to
general practitioners. Ignorance of national guidelines and fear of missing
a breast cancer results in a large number of patients being referred to the
breast clinic with signiﬁcant resource implications. GPs should be
encouraged to manage mastalgia in the community. We would advice
breast specialists to assume a primary role in promoting knowledge and
reassurance amongst GPs by means of leaﬂets, forums and meetings.
0132: PHYLLOIDES TUMOURS OF THE BREAST: A SINGLE CENTRE
EXPERIENCE
Valentina Lefemine, Gary Osborn, Verity Oloroso, Carrie Champ, Kate
Gower-Thomas, Rhodri Williams, Eiﬁon Vaughan-Williams. Royal
Glamorgan Hospital, Llantrisant, UK
Aims: Phylloides tumours (PT) are the most common non epithelial
neoplasms of the breast and account for 1% of all breast tumours. We aim
to report our experience on the management of PT over an eight year
period.
Methods: A retrospective review of all patients diagnosed with PT in
a single unit between January 2003 and December 2010 was performed.
Results: 31 patients were included. 27 patients had symptomatic and 4
patients screen detected lesions. Diagnostic imaging showed benign
features in 13 patients, equivocal features in 9 patients and features in
keeping with PT in 9 patients. All lesions were biopsied but a preoperative
diagnosis of PT was achieved in only 10 patients. 4 patients underwent
mastectomy,27 patients had a wide local excision. Final histology revealed
23 benign and 8 malignant PT. All patients were followed up for 12
months; we had a 9.6% recurrence rate, mostly in patients with benign
phylloides.
Conclusions: PT of the breast are a diagnostic challenge. There is a lack of
consensus on how to best manage these rare tumours and we would
recommend a low threshold for excising rapidly growing or large
supposedly benign lesions. All patients should be followed up as even
benign phylloides can reoccur.
0176: BREAST CANCER IN SYMPTOMATIC PATIENTS WHO HAVE
NORMAL USS AND/OR MAMMOGRAM
Andrew Mishreki, Syed Yousuf, Ranya Bafadal, Catherine
Chikerema. University Hospital North Durham, Durham, UK
Aim: There is no data published on the incidence of patients who present
to the breast clinic (with either a lump or thickening) and have normal
ﬁndings on USS and/or mammogram, however subsequently have biopsy
proven cancers.
The aim of our study was to determine this number in our centre.
Method: We called all of the patient's notes who were diagnosed with
breast cancer between 1st April 2009 and 31st October 2011 in our trust.
We retrospectively reviewed all presenting complaints, radiology and
histology ﬁndings, and multi-disciplinary team meeting decisions.
Results: In total we found 319 patients who were diagnosed with breast
cancer during this period.
Out of these 17 had normal imaging initially, however had histologically
conﬁrmed breast cancer/in-situ cancer on FNAC/core biopsy of the
symptomatic area.
